Lilly Provides Update on CEO Dr. John Lechleiter
INDIANAPOLIS, May 14, 2013
INDIANAPOLIS, May 14, 2013 /PRNewswire/ --Eli Lilly and Company (NYSE:LLY)
today announced that John C. Lechleiter, Ph.D., chairman, president, and chief
executive officer, underwent scheduled surgery for a dilated aorta on Monday,
May 13, 2013.
"Dr. Lechleiter's surgeons have advised us that surgery went as expected and
the repair to the aorta is functioning as intended," said Kristine A.
Courtney, M.D., senior director of Lilly's corporate health services. "Dr.
Lechleiter is recovering and will be closely monitored by the medical staff
over the next several days."
As announced previously, in accordance with the company's bylaws, Derica W.
Rice, executive vice president, global services and chief financial officer,
has assumed the additional role of acting chief executive officer during
Lechleiter's recuperation period. Ellen R. Marram, currently the board's lead
independent director, is serving as acting chairperson of the board of
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing
portfolio of pharmaceutical products by applying the latest research from its
own worldwide laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Ind., Lilly provides answers-
through medicines and information- for some of the world's most urgent
medical needs. Additional information about Lilly is available at
(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )
Refer to: (317) 433-9899 – Edward Sagebiel; email@example.com
(317) 276-5795 – Mark Taylor; firstname.lastname@example.org
SOURCE Eli Lilly and Company
Press spacebar to pause and continue. Press esc to stop.